Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb 21;20(7):1797-806.
doi: 10.3748/wjg.v20.i7.1797.

Increased susceptibility to Trichuris muris infection and exacerbation of colitis in Mdr1a-/- mice

Affiliations

Increased susceptibility to Trichuris muris infection and exacerbation of colitis in Mdr1a-/- mice

Ekta K Bhardwaj et al. World J Gastroenterol. .

Abstract

Aim: To investigate the influence of Trichuris muris (T. muris) infection in a mouse model of genetic susceptibility to inflammatory bowel disease, Mdr1a-/-.

Methods: Mdr1a-/- mice were housed under specific pathogen free conditions to slow the development of colitis and compared to congenic FVB controls. Mice were infected with approximately 200 embryonated ova from T. muris and assessed for worm burden and histological and functional markers of gut inflammation on day 19 post infection.

Results: Mdr1a-/- mice exhibited a marked increase in susceptibility to T. muris infection with a 10-fold increase in colonic worm count by day 19 pi compared to FVB controls. Prior to infection, Mdr1a-/- exhibited low-level mucosal inflammation with evidence of an enhanced Th1 environment. T. muris infection accelerated the progression of colitis in Mdr1a-/- as evidenced by marked increases in several indicators including histological damage score, mucosal CD⁺ T-cell and DC infiltration and dramatically increased production of pro-inflammatory cytokines.

Conclusion: These data provide further evidence of the complex interaction between T. muris and an inflammatory bowel disease (IBD)-susceptible host which may have relevance to the application of helminth therapy in the treatment of human IBD.

Keywords: Colitis; Helminth; Inflammatory bowel disease; Mdr1a; P-glycoprotein.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mdr1a-/- (KO) mice show increased susceptibility to Trichuris muris infection compared to FVB controls (WT). Data shows large intestinal worm burden measured on day 19 following infection with approximately 200 embryonated Trichuris muris eggs. Each data point represents a single mouse (n = 6 in each group); the horizontal bar denotes the mean for each group. bP < 0.01.
Figure 2
Figure 2
Parasite-specific IgG1 and IgG2a antibody responses in the serum of naïve and Trichuris muris infected FVB (WT) and mdr1a-/- (KO) mice. Serum was taken from mice at day 19 post infection. Data shows mean ± SD for n = 5-7 animals in each group. OD: Optical density.
Figure 3
Figure 3
Cytokine production by mesenteric lymph nodes from naïve and Trichuris muris infected FVB (WT) and mdr1a-/- (PGP-KO) mice. Levels of Th1 [interferon (IFN)γ, A; interleukin (IL)-12p40, C] and Th2 (IL-13, D; IL-5, E) and the pro-inflammatory cytokine [tumor necrosis factor (TNF)α, B] were measured in mesenteric lymph nodes (MLN) following in vitro stimulation with Trichuris muris (T. muris) E/S antigen. MLN were isolated on day 19 post infection in T. muris infected groups. Data is shown as mean + SD for n = 5 animals in each group aP < 0.05; bP < 0.01.
Figure 4
Figure 4
Expression of interferon γ-dependent genes IDO and CXCL-10 in colonocytes from naïve Mdr1a-/- and FVB mice. mRNA expression was measured relative to β-actin in each case. Data is expressed as fold change in expression in Mdr1a-/- colonocytes relative to FVB controls and is shown as mean ± SD for n = 4 preparations for each group. aP < 0.05, bP < 0.01 vs FVB groups.
Figure 5
Figure 5
Histological analysis of proximal colon from FVB (WT) and mdr1a-/- (PGP-KO) mice. A-E: H and E stained sections from proximal colon of WT-N (A), WT-INF (B), KO-N (C) and KO-INF (D-E). Tissues were isolated on day 19 post-infection in Trichuris muris (T. muris) infected mice; F: Histological disease scores for colon from naïve (WT-N; KO-N) and T. muris infected (WT-INF; KO-INF) mice based on the grading system described by Collett et al[11], 2008. Bar shows mean values for each group aP < 0.05, bP < 0.01, n = 5 for each group.
Figure 6
Figure 6
CD4+ T-cell infiltration associated with Trichuris muris infection in the proximal colon of FVB (WT) and mdr1a-/- (PGP-KO) mice. A: Immunohistochemical staining for CD4+ T cells in naïve (WT-N; KO-N) and Trichuris muris (T. muris) infected (WT-INF; KO-INF) WT and PGP-KO mice; B: Mean data (± SD) from 5 animals in each group showing CD4+ T cells present per 20 crypts units. Tissues were isolated on day 19 post-infection in T. muris infected mice, bP < 0.01.
Figure 7
Figure 7
Dendritic cell infiltration associated with Trichuris muris infection in the proximal colon of FVB (WT) and mdr1a-/- (PGP-KO) mice. Fluorescence staining (pink) for dendritic cells in frozen sections of proximal colon from naïve (WT-N; KO-N) and Trichuris muris (T. muris) infected (WT-INF; KO-INF) mice. Tissues were removed on day 19 post infection in T. muris infected mice. Original magnification × 20. Images are representative of tissues from 5 mice in each group.

Similar articles

Cited by

References

    1. Cliffe LJ, Grencis RK. The Trichuris muris system: a paradigm of resistance and susceptibility to intestinal nematode infection. Adv Parasitol. 2004;57:255–307. - PubMed
    1. Else KJ. Have gastrointestinal nematodes outwitted the immune system? Parasite Immunol. 2005;27:407–415. - PubMed
    1. Wang LJ, Cao Y, Shi HN. Helminth infections and intestinal inflammation. World J Gastroenterol. 2008;14:5125–5132. - PMC - PubMed
    1. Summers RW, Elliott DE, Urban JF, Thompson R, Weinstock JV. Trichuris suis therapy in Crohn’s disease. Gut. 2005;54:87–90. - PMC - PubMed
    1. Summers RW, Elliott DE, Urban JF, Thompson RA, Weinstock JV. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology. 2005;128:825–832. - PubMed

MeSH terms

Substances